Porth's Essentials of Pathophysiology, 4e

954

Nervous System

U N I T 1 0

49. Kuttesch JF Jr, Rush SZ, Ater JL. Brain tumors in childhood. In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: Saunders Elsevier; 2011:1747e1–1753.e1. 50. Ostrom QT, Barnabulz-Sloan JS. Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep. 2011;11:329–335. 51. Sagar SM, Isrel MA. Primary and metastatic tumors of the nervous system. In: Hauser SL, ed. Harrison’s Neurology in Clinical Practice . 2nd ed. New York, NY: McGraw-Hill; 2010:408–422. 52. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507. 53. Nguyen TD, DeAngelis LM. Brain metastases. Neurol Clin. 2007;25:1173–1192. 54. Nguyen TD, Abrey LS. Brain metastasis: old problems, new strategies. Hematol Oncol Clin North Am 2007;21:369–387. 55. Lowenstein DH. Seizures and epilepsy. In: Hauser SL, ed. Harrison’s Neurology in Clinical Practice . 2nd ed. New York, NY: McGraw-Hill; 2010:222–245. 56. National Library Medicine & National Institutes of Health. Epilepsy 2013. MedlinePlus. Available at: http://www.ninds.nih. gov/disorders/epilepsy/detail_epilepsy.htm. Accessed June 13, 2013. 57. Mikati MA. Seizures in childhood. In Kleigman RM, Stanton BF, St. Geme JW, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: Elsevier Saunders; 2011:2013e1–2039.e1. 58. French JA, Pedley TA. Initial management of epilepsy. N Engl J Med. 2008;359(2):166–176. 59. Schachter SC. Seizure disorders. Med Clin North Am. 2009;93: 343–351. 60. Dube C, Brewster AL, Baram TZ. Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev. 2009;31(5):366–371. 61. Berg A, Berkovic S, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–685. 62. Wilden JA, Cohen-Gadol A. Evaluation of first nonfebrile seizure. Am Fam Physician. 2012;86(4):334–340. 63. Porter RJ, Meldrum MB. Antiseizure drugs. In Katzung BG, ed. Basic and Clinical Pharmacology . 12th ed. New York, NY: McGraw-Hill Medical; 2012:403–427. 64. Privitera M. Current challenges in the management of epilepsy. Am J Manag Care. 2011;17(7S):195–203. 65. Asconapé JJ. Epilepsy: new drug targets and neurostimulators. Neurol Clin. 2013;31:785–798. 66. Khaled KJA, Hirsch LJ. Updates in the management of seizures and status epilepticus in critically ill patients. Neurol Clin. 2008;26:385–408. 67. Peterson RC. Mild cognitive impairment. N Engl J Med. 2011;364:2227–2234.

68. Josshi S, Morley JE. Cognitive impairment. Med Clin North Am. 2006;90:769–787. 69. Bird TD, Miller BL. Alzheimer’s disease and other dementias. In Hauser SL, ed., Harrison’s Neurology in Clinical Medicine . 2nd ed. New York, NY: McGraw-Hill; 2010:298–319. 70. Alzheimer’s Association. 2013 Alzheimer’s disease: Facts and Figures 2013:1–71. Available at: http://www.alz.org/professionals_ and_researchers. Accessed June 12, 2013. 71. Querfurth HW, LaFerla FM. Alzheimer disease. N Engl J Med. 2010;362:329–344. 72. Mongialache F, Solomon A, Mecocci P, et al. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 2010;9: 202–216. 73. Katzung BG. Special aspects of geriatric pharmacology. In: Katzung BG, ed. Basic and Clinical Pharmacology . 12th ed. New York, NY, McGraw-Hill Medical; 2012:403–427, 1054–1055. 74. Kotczyn AD, Vakhopova V, Grinberg LT. Vascular dementia. J Neurol Sci 2012;322:2–10. 75. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from American Heart Association/American Stroke Association. Stroke. 2011;42:2672–2713. 76. Thai DR, Grinberg LT, Atterns J. Vascular dementia: different forms of vessel disorders contribute to development of dementia in elderly brains. Exp Gerontol. 2012;47:816–824. 77. Cardarelli R, Kertesz A, Knebl JA. Frontotemporal dementia: a review for primary care physicians. Am Fam Physician. 2010;82(11):1372–1377. 78. Arvanitakis Z. Update on frontotemporal dementia. Neurologist. 2010;16(1):16–22. 79. Sturrock A, Leavitt BR. The clinical and genetic features of Huntington’s disease. J Geriatr Psychiatry. 2013;23(4):243–259. 80. Huntington’s Disease Society of America. A juvenile HD handbook . [Online]. Available at: http://www.hdsa.org/images/ content/1/1/11702.pdf. Accessed November 7, 2013. 81. Cardosa F. Huntington disease and other choreas. Neurol Clin. 2009;27:719–736.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Concepts in Action Animations • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu